1-3 of 3
Christopher R. Frei
Close
Sort by
Journal Articles

Shift in First-Line Therapies for United States Veterans Health Administration (VHA) Patients with Chronic Lymphocytic Leukemia (CLL) from 2014 to 2021

Kana Tai Lucero, Christopher R. Frei, Kellie J. Ryan, Obiageri O. Obodozie-Ofoegbu, Amanda M. Moore, Chengwen Teng, Xavier Jones, Zohra Nooruddin
Journal: Blood
Blood (2022) 140 (Supplement 1): 9915–9916.
https://doi.org/10.1182/blood-2022-163797
Published: 2022
Journal Articles

Uptake of Novel Agents (NAs) As First-Line Treatments for Black and White Patients with Chronic Lymphocytic Leukemia (CLL) in the Veterans Health Administration (VHA): A Retrospective Cohort Study

Kana Tai Lucero, Obiageri O. Obodozie-Ofoegbu, Zohra Nooruddin, Alyssa Castillo, Amanda M. Moore, Kellie J. Ryan, Xavier Jones, Christopher R. Frei
Journal: Blood
Blood (2021) 138 (Supplement 1): 340.
https://doi.org/10.1182/blood-2021-146860
Published: 2021
Journal Articles

Treatment Patterns and Outcomes of 1205 Patients on Novel Agents in the US Veterans Health Administration (VHA) System: Results from the Largest Retrospective EMR and Chart Review Study in the Real-World Setting

Christopher R Frei, Hannah Le, PharmD, MPH, Daniel McHugh, Cynthia Elesinmogun, PharmD, Samantha Galley, Kathleen Franklin, Juan Tavera, Michelle Janania Martinez, MD, David J Gregorio, DO, Snegha Ananth, MBBS, Ricardo Uribe, Prathibha Surapaneni, Manuel Ricardo Espinoza-Gutarra, MD, Michael Song, Xavier Jones, Chengwen Teng, Obiageri O Obodozie-Ofoegbu, Zohra Nooruddin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 795.
https://doi.org/10.1182/blood-2019-122434
Published: 2019